| The Burden of NSAID-ERD: Interplay between Quality of Life and Economic Implications NR Rowan, C Hopkins, RJ Schlosser, ZM Soler The Journal of Allergy and Clinical Immunology: In Practice, 2024 | | 2024 |
| Recovery rates and long-term olfactory dysfunction following COVID-19 infection M Dias, Z Shaida, N Haloob, C Hopkins World Journal of Otorhinolaryngology-Head and Neck Surgery 10 (02), 121-128, 2024 | | 2024 |
| Antibody-based therapeutics for chronic rhinosinusitis with nasal polyps S Shishodia, N Haloob, C Hopkins Expert Opinion on Biological Therapy, 2024 | | 2024 |
| Quality of Life in Symptomatic Septal Perforation. MJ Rojas-Lechuga, M Quer-Castells, N González-Sánchez, ... The Laryngoscope, 2024 | | 2024 |
| Assessment of chronic rhinosinusitis with nasal polyps: Development of the Nasal Polyp Patient Assessment Scoring Sheet tool S Alsaleh, N Kamal, C Hopkins, H Al Rand, OA Marglani, A Alterki, ... Laryngoscope investigative otolaryngology 9 (3), e1277, 2024 | | 2024 |
| SARS-CoV-2 vaccination may help patients with persistent COVID-19 smell dysfunction JR Lechien, C Hopkins, LA Vaira, S Saussez Ear, Nose & Throat Journal 103 (1_suppl), 3S-4S, 2024 | 4 | 2024 |
| Pre-asthma: a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma GK Scadding, C Gray, DM Conti, M McDonald, V Backer, G Scadding, ... Frontiers in allergy 5, 1404735, 2024 | | 2024 |
| Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo‐controlled OSTRO trial C Emson, JK Han, C Hopkins, S Asimus, JA Cann, D Chain, Y Wu, ... British Journal of Clinical Pharmacology, 2024 | | 2024 |
| EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care PW Hellings, I Alobid, WT Anselmo‐Lima, M Bernal‐Sprekelsen, ... Allergy 79 (5), 1123-1133, 2024 | 4 | 2024 |
| Impact of dupilumab on Sinonasal Symptoms and outcomes in Severe Chronic Rhinosinusitis with nasal polyps C Hopkins, J Mullol, AH Khan, SE Lee, M Wagenmann, P Hellings, ... Otolaryngology–Head and Neck Surgery 170 (4), 1173-1182, 2024 | 1 | 2024 |
| Time to toughen up against sexual harrassment in surgery C Hopkins The Bulletin of the Royal College of Surgeons of England 106 (2), 56-57, 2024 | | 2024 |
| Long-term effectiveness of benralizumab in eosinophilic granulomatosis with polyangiitis AM Nanzer, AC Maynard-Paquette, V Alam, L Green, L Thomson, J Lam, ... The Journal of Allergy and Clinical Immunology: In Practice 12 (3), 724-732, 2024 | 2 | 2024 |
| International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction KL Whitcroft, I Alobid, A Altundag, P Andrews, S Carrie, M Fahmy, ... Clinical Otolaryngology 49 (2), 220-234, 2024 | 2 | 2024 |
| Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and … C Bachert, AH Khan, SE Lee, C Hopkins, AT Peters, W Fokkens, ... International forum of allergy & rhinology 14 (3), 668-678, 2024 | 9 | 2024 |
| Profiling Symptomatic and Quality of Life Benefits of Mepolizumab for Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) in the SYNAPSE Trial L Borish, J Silver, L Baylis, P Howarth, R Chan, P Dsilva, C Hopkins, ... Journal of Allergy and Clinical Immunology 153 (2), AB252, 2024 | | 2024 |
| International consensus statement on allergy and rhinology: sinonasal tumors EC Kuan, EW Wang, ND Adappa, DM Beswick, NR London Jr, SY Su, ... International forum of allergy & rhinology 14 (2), 149-608, 2024 | 23 | 2024 |
| Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma GK Scadding, M McDonald, V Backer, G Scadding, M Bernal-Sprekelsen, ... Frontiers in allergy 4, 1291185, 2024 | 2 | 2024 |
| EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. WJ Fokkens, E De Corso, V Backer, M Bernal-Sprekelsen, L Bjermer, ... Rhinology, 2024 | 8 | 2024 |
| Quality of Life in Symptomatic Septal Perforation B Alegre Edo, MJ Rojas‐Lechuga, M Quer‐Castells, ... The Laryngoscope, 2024 | | 2024 |
| Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial WJ Fokkens, C Bachert, C Hopkins, O Marglani, A Praestgaard, S Nash, ... Clinical & Translational Immunology 13 (6), e1511, 2024 | | 2024 |
